Boston University

Antibiotics

Scientific illustration of Carbapenem-resistant Enterobacteriaceae (CRE), otherwise known as Nightmare Bacteria.

Superbugs

Superbug detector is first diagnostic to launch from CARB-X

September 24, 2019

sperm and egg

BIRTH CONTROL

Why We Need a Contraception Revolution

August 1, 2019

Detail photo of a researcher demonstrating a drug-free blue light therapy MRSA treatment. The researcher exposes a petri dish of MRSA and hydrogen peroxide to a blue light laser light.

Photonics

How Light Turns Ordinary Hydrogen Peroxide into a MRSA Treatment

April 9, 2019

Assistant Professor Mary Dunlop (right) and postdoctoral fellow Imane El Meouche in a lab

Antibiotics

Antibiotic Resistance without the Antibiotics

December 11, 2018

Synthetic biology researcher Ahmad "Mo" Khalil, assistant professor of biological engineering at Boston University, and researcher at the Boston University Biological Design Center

Engineering Biology

Hacking Nature

May 10, 2017

Kevin Outterson, N. Neal Pike Scholar in Health and Disability Law, leads CARB-X, world’s largest public-private partnership to accelerate development of urgently needed new antimicrobials.

Antibiotics

LAW-based CARB-X Awards $24 Million for Superbug Antibiotics

March 31, 2017

Ahmad “Mo” Khalil, Assistsant Professor of Biomedical Engineering, Boston University

Engineering Biology

Khalil Wins NIH New Innovator Award

December 21, 2016

Kevin Outterson, professor of health law, Boston University School of Law

Antibiotics

Law School Guides Global Effort to Create New Antibiotics

July 28, 2016

Law School Guides Global Effort to Create New Antibiotics